Clinical Research Directory
Browse clinical research sites, groups, and studies.
Descartes-08 CAR-T Cells in Generalized Myasthenia Gravis (MG)
Sponsor: Cartesian Therapeutics
Summary
This is a Phase IIb study to evaluate the safety and preliminary efficacy of Descartes-08 CAR T-cells in patients with Generalized Myasthenia Gravis
Official title: Autologous T-Cells Expressing A Chimeric Antigen Receptor Directed To B-Cell Maturation Antigen (BCMA) In Patients With Generalized Myasthenia Gravis (MG)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2019-12-04
Completion Date
2026-03-31
Last Updated
2025-05-28
Healthy Volunteers
No
Conditions
Interventions
Descartes-08
Autogolous T-cells expressing a chimeric antigen receptor directed to BCMA
Locations (15)
Profound Research
Carlsbad, California, United States
University of California Irvine
Irvine, California, United States
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
SFM Clinical Research, LLC
Boca Raton, Florida, United States
Neurology Associates, P.A.
Orlando, Florida, United States
University of South Florida
Tampa, Florida, United States
University of Augusta
Augusta, Georgia, United States
University of Kansas Medical Center Research Institute
Kansas City, Kansas, United States
Dent Neurologic Institute
Amherst, New York, United States
University of North Carolina
Chapel Hill, North Carolina, United States
Oregon Health & Science University
Portland, Oregon, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
Allegheny Health Network
Pittsburgh, Pennsylvania, United States
Virginia Commonwealth University
Richmond, Virginia, United States
University of Alberta
Edmonton, Alberta, Canada